Veritable, L.P. Buys iShares MSCI EAFE Value ETF, Corteva Inc, Toll Brothers Inc, Sells DuPont de Nemours Inc, Vanguard FTSE All-World ex-US ETF, Vanguard Energy ETF

• New Purchases: CTVA, DOX, CCC, ALC, MHK, JPC, TECH, WAB, GNRC, CBOE, XYL, RESI, FEYE, AXTA, VRRM, COLD, REZI, IEUR, VGLT, CLNY, BEP, LULU, L, WWD, VIAB, SIVB, ORI, NDSN, MIDD, MKTX, MKL, IAC, HAS,
• Added Positions: IVV, IJH, EFV, VYM, TOL, VWO, MMM, CB, T, AAP, CCI, XRAY, FAST, GE, HRC, HST, IBM, MDT, UPS, UNH, VTR, WFC, FB, GOOG, INVH, IGF, IJR, ACN, AFL, ALXN, ALGN, ADS, ALL, MO, ACC, ABC, AMGN, APA, WTR, ATO, AZO, BBT, BBVA, SAN, BXP, BSX, BDN, CBRE, CF, CHRW, CVS, COF, KMX, CCL, CE, CELG, CTL, CERN, CME, CHD, C, CTXS, CL, ED, STZ, COO, CUZ, DTE, DISCA, DLB, DRE, ETFC, EOG, EWBC, EMN, EIX, EA, EMR, ETR, EFX, EQR, EXPE, FDS, FE, F, RHP, GIS, GPC, GPK, HRB, MNST, LHX, HIG, HCP, HSIC, HOLX, IFF, IP, JBHT, JEC, JCI, KSU, LH, LVS, LEN, LPT, LNC, LGF.B, LYG, MMC, MAS, MCK, MAA, NATI, NTAP, NWL, NEM, NI, NKE, NSC, NTRS, NVS, NUE, PCAR, PPL, PEI, PRU, PSA, O, RNR, RIO, ROP, ROST, SAP, SWM, SON, STE, TCO, TXT, TTC, TSCO, CUBE, UAL, UDR, URI, VMC, AGN, WLTW, XEL, NAD, HBI, WU, BR, CXO, MSCI, PM, CFX, PEB, PDM, HPP, TSLA, LYB, GM, HCA, HII, VER, ZNGA, WP, RPAI, NOW, FIVE, WDAY, ABBV, IQV, QTS, TWTR, ALLE, SABR, ZEN, ANET, SERV, GDDY, CC, BHF, CVET, AMJ, IWN, IYR, PBW, PFF, XLC,
• Reduced Positions: XLE, IWB, IWR, VTI, DD, MUB, IWM, VDE, VEU, VO, XOM, XLK, XLF, XLY, MA, LQD, VEA, XLV, AMD, CVX, COP, OXY, JNK, VIOO, XLI, XLP, ARE, AMZN, BIIB, CINF, CSCO, COST, EGBN, EPD, EXPD, IT, GOOGL, HEI, INFO, IPG, JPM, LMT, MMP, MRK, MSFT, PAYX, PKI, PFE, SLB, SCI, SBUX, UNP, ET, WBC, VRSK, KMI, MPLX, PYPL, FOXA, AAXJ, MDYG, VB, VGT, VNQ, XLB, XLRE, XLU, AES, ASML, ABT, ABMD, ATVI, ADBE, A, APD, AKAM, Y, HES, AXP, AME, APH, APC, ANSS, AON, AMAT, ADM, ARW, AZN, AVB, AVY, BP, BIDU, BMO, BK, BAX, BDX, BLK, BAM, BRO, BF.B, CPB, CP, CAH, CAT, CNC, CNP, SCHW, CI, CLX, CSGP, DXC, CAG, CPRT, GLW, CCK, DHR, DE, DEO, DLR, D, DPZ, DOV, DUK, ECL, ENB, EQIX, EL, EXC, FMC, NEE, FICO, FDX, FITB, FRME, FCX, GD, GS, HDB, HAL, HELE, HPQ, HON, IR, KMB, MDLZ, KR, LRCX, LYV, MRO, MAR, MLM, MKC, SPGI, MET, MTD, MU, MS, MSI, NVDA, NYCB, NBL, ORLY, OMC, OKE, ORCL, PPG, PTC, PH, PEP, PXD, BKNG, PFG, PGR, PEG, QCOM, RHT, REG, REGN, RMD, WRK, ROK, RCL, RDS.A, SBAC, SEIC, CRM, SNY, SHW, SPG, SIRI, SO, LUV, SWK, STT, SYK, SUI, TJX, TFX, TER, TXN, TMO, TRMB, TSN, UL, UNM, MTN, VZ, VNO, WRB, GWW, WBA, WCN, WAT, WY, WMB, WSM, WEC, XLNX, ZBH, EBAY, CMG, TDG, QRTEA, DEI, LBTYK, TMUS, DAL, AWK, TDC, ULTA, V, DISCK, STWD, H, CHTR, SSNC, BWXT, BAH, CZR, FRC, MPC, WPX, HTA, FANG, WES, BFAM, ZTS, CDW, NWSA, VEEV, CXP, BRX, ARMK, HLT, BABA, CFG, KEYS, SHOP, BZUN, KHC, WBT, LSXMA, LSXMK, FTV, YUMC, LW, LEXEA, AYX, JBGS, BHGE, EYE, CDAY, DOW, BND, BSV, DBC, EEMV, GLD, GNR, HYG, IEFA, IWO, IWP, IWS, IXC, IYE, KBE, RSP, VGK, VOX, VPL, VTIP,
• Sold Out: XOP, VLUE, IBB, EWC, CSL, GIL, PK, LC, OLED, NLSN, MOS, TRIP, PANW, MRIN, NAVI, AA, NIO, BUD, FTI, LMST, OPK, SWKS, STX, PVH, OGE, KSS, HCSG, BMRN, BMS, GOLD, AIV,

For the details of Veritable, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/veritable%2C+l.p./current-portfolio/portfolioportfolio

1. SPDR S&P 500 ETF Trust (SPY) - 2,462,314 shares, 14.40% of the total portfolio. Shares added by 0.45%
2. SPDR S&P MidCap 400 ETF (MDY) - 1,354,672 shares, 9.59% of the total portfolio. Shares reduced by 0.52%
3. iShares Core S&P 500 ETF (IVV) - 1,280,846 shares, 7.53% of the total portfolio. Shares added by 2.74%
4. Vanguard S&P 500 ETF (VOO) - 1,166,520 shares, 6.27% of the total portfolio. Shares reduced by 0.88%
5. iShares Russell 1000 ETF (IWB) - 1,164,454 shares, 3.78% of the total portfolio. Shares reduced by 5.84%

Veritable, L.P. initiated holding in Corteva Inc. The purchase prices were between $24.81 and $29.57, with an estimated average price of $27.28. The stock is now traded at around $29.59. The impact to a portfolio due to this purchase was 0.04%. The holding were 67,744 shares as of .

Veritable, L.P. initiated holding in Amdocs Ltd. The purchase prices were between $53.32 and $62.37, with an estimated average price of $57.74. The stock is now traded at around $63.65. The impact to a portfolio due to this purchase was 0.01%. The holding were 7,147 shares as of .

Veritable, L.P. initiated holding in Westinghouse Air Brake Technologies Corp. The purchase prices were between $62.38 and $77.93, with an estimated average price of $70.92. The stock is now traded at around $68.19. The impact to a portfolio due to this purchase was 0.01%. The holding were 5,754 shares as of .

Veritable, L.P. initiated holding in Nuveen Preferred & Income Opportunities Fund. The purchase prices were between $9.32 and $9.91, with an estimated average price of $9.65. The stock is now traded at around $9.81. The impact to a portfolio due to this purchase was 0.01%. The holding were 75,000 shares as of .

Veritable, L.P. initiated holding in Bio-Techne Corp. The purchase prices were between $188.72 and $215.43, with an estimated average price of $201.3. The stock is now traded at around $190.61. The impact to a portfolio due to this purchase was 0.01%. The holding were 2,065 shares as of .

Veritable, L.P. initiated holding in Alcon Inc. The purchase prices were between $54.43 and $63.33, with an estimated average price of $58.65. The stock is now traded at around $59.40. The impact to a portfolio due to this purchase was 0.01%. The holding were 4,173 shares as of .

Veritable, L.P. added to a holding in iShares MSCI EAFE Value ETF by 29.63%. The purchase prices were between $45.64 and $49.13, with an estimated average price of $47.65. The stock is now traded at around $44.69. The impact to a portfolio due to this purchase was 0.05%. The holding were 233,270 shares as of .

Veritable, L.P. added to a holding in Toll Brothers Inc by 81.41%. The purchase prices were between $34.77 and $39.22, with an estimated average price of $37.34. The stock is now traded at around $35.47. The impact to a portfolio due to this purchase was 0.02%. The holding were 54,268 shares as of .

Veritable, L.P. added to a holding in Hill-Rom Holdings Inc by 145.72%. The purchase prices were between $93.98 and $106.69, with an estimated average price of $101. The stock is now traded at around $106.39. The impact to a portfolio due to this purchase was 0.01%. The holding were 5,315 shares as of .

Veritable, L.P. added to a holding in Dentsply Sirona Inc by 22.92%. The purchase prices were between $48.76 and $58.88, with an estimated average price of $53.67. The stock is now traded at around $52.28. The impact to a portfolio due to this purchase was 0.01%. The holding were 22,780 shares as of .

Veritable, L.P. added to a holding in Fastenal Co by 101.18%. The purchase prices were between $30.38 and $35.68, with an estimated average price of $32.98. The stock is now traded at around $29.39. The impact to a portfolio due to this purchase was 0.01%. The holding were 10,956 shares as of .

Veritable, L.P. added to a holding in Invitation Homes Inc by 38.86%. The purchase prices were between $23.99 and $27.75, with an estimated average price of $25.46. The stock is now traded at around $27.80. The impact to a portfolio due to this purchase was 0.01%. The holding were 36,020 shares as of .

Veritable, L.P. sold out a holding in SPDR S&P Oil & Gas Exploration & Production ETF. The sale prices were between $24.86 and $32.98, with an estimated average price of $28.88.

Veritable, L.P. sold out a holding in Carlisle Companies Inc. The sale prices were between $124.09 and $141.42, with an estimated average price of $134.43.

Veritable, L.P. sold out a holding in iShares Edge MSCI USA Value Factor ETF. The sale prices were between $74.66 and $83.24, with an estimated average price of $80.13.

Veritable, L.P. sold out a holding in iShares MSCI Canada ETF. The sale prices were between $27.08 and $28.77, with an estimated average price of $27.96.

Veritable, L.P. sold out a holding in LendingClub Corp. The sale prices were between $13.8 and $18.1, with an estimated average price of $15.77.

Veritable, L.P. sold out a holding in iShares Nasdaq Biotechnology Index Fund. The sale prices were between $99.98 and $114.93, with an estimated average price of $106.31.